Leveraging 3D-printed microfluidic micromixers for the continuous manufacture of melatonin loaded SNEDDS with enhanced antioxidant activity and skin permeability
![Leveraging 3D-printed microfluidic micromixers for the continuous manufacture of melatonin loaded SNEDDS with enhanced antioxidant activity and skin permeability](https://www.pharmaexcipients.com/wp-content/uploads/2024/08/Leveraging-3D-printed-microfluidic-micromixers-for-the-continuous-manufacture-of-melatonin-loaded-SNEDDS-with-enhanced-antioxidant-activity-and-skin-permeability.jpg)
Vesicants are chemical warfare agents (CWAs) capable of causing severe skin damage and systemic toxicity. Melatonin, known for its anti-inflammatory and antioxidant properties, can mitigate the effects of these agents. Self-nano-emulsifying drug delivery systems (SNEDDS) containing a high melatonin concentration (5 %, 50 mg/g) were optimized using a quality-by-design approach from biocompatible, non-irritant excipients with a particle size of about 100 nm. The melatonin-loaded SNEDDS showed a 43-fold greater permeability than a conventional melatonin cream.
Chemical stability at ambient temperature (25 °C) was maintained for one year. The preparation of optimised melatonin-loaded SNEDDS using a simple mixing method was compared to microfluidic micromixers. Mixing was successfully achieved using a 3D-printed (fused deposition modeling or stereolithography) T-shaped toroidal microfluidic chip (with a channel geometry optimized by computational fluid dynamics), resulting in a scalable, continuous process for the first time with a substantial reduction in preparation time compared to other conventional mixing approaches.
No statistically significant differences were observed in the key quality attributes, such as particle size and melatonin loading, between the conventional mixing method in a water bath to reach equilibrium solubility and the use of 3D-printed micromixers. This scalable, continuous, cost-effective approach improves the overall efficiency of SNEDDS production, reduces the cost of quality control for multiple batches, and demonstrates the potential of microfluidic manufacturing with readily customizable 3D-printed micromixers at points of care such as military bases.
Download the full article as PDF here Leveraging 3D-printed microfluidic micromixers for the continuous manufacture of melatonin loaded SNEDDS with enhanced antioxidant activity and skin permeability
or read it here
Materials
Melatonin (Ph. Eur. Grade) was purchased from Fagrón Ibérica SAU (Madrid, Spain). SNEDDS excipients, Capryol® 90 (propylene glycol monocaprylate), Labrafil® M 1944 CS (oleoyl polyoxyl-6 glycerides), Labrasol® (caprylocaproyl polyoxyl-8 glycerides), Labrafac® PG (propylene glycol dicaprylocaprate) and Labrafac® lipophile WL 1349 (consisting of medium-chain triglycerides of caprylic (C8) and capric (C10) acids) were donated by Gattefossé (Saint-Priest Cedex, France). Propylene Glycol, Tween® 80
Baris Ongoren, Aytug Kara, Luca Casettari, Mattia Tiboni, Aikaterini Lalatsa, Amadeo Sanz-Perez, Elena Gonzalez-Burgos, Alejandro Romero, Antonio Juberías, Juan J. Torrado, Dolores R. Serrano, Leveraging 3D-printed microfluidic micromixers for the continuous manufacture of melatonin loaded SNEDDS with enhanced antioxidant activity and skin permeability, International Journal of Pharmaceutics, 2024, 124536, ISSN 0378-5173, https://doi.org/10.1016/j.ijpharm.2024.124536.
Read also our introduction article on 3D Printing here:
![3D Printing](https://www.pharmaexcipients.com/wp-content/uploads/2024/07/3D-Printing-300x169.png)